Long-term prospective randomized study comparing two different regimens of oxybutynin as a treatment for detrusor overactivity

This study did not show any advantage in efficacy or compliance with oxybutynin when two different regimens of low starting were used. Two-thirds of patients discontinued the therapy within 4-6 months. Therefore, patients on anticholinergics should be reassessed after 6 months in clinical practice.